Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model

Liver Transplantation

Volumn 13, Issue 10, 2007, Pages 1435-1443

  Shen, Xiu Da ^a   Ke, Bibo ^a   Zhai, Yuan ^a   Gao, Feng ^a   Tsuchihashi, Sei Ichiro ^a   Lassman, Charles R ^b   Busuttil, Ronald W ^a   Kupiec Weglinski, Jerzy W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CD34 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEME OXYGENASE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GRAFT SURVIVAL; HISTOPATHOLOGY; KNOCKOUT MOUSE; LIVER CELL; LIVER CELL DAMAGE; LIVER GRAFT; LIVER ISCHEMIA; LIVER PRESERVATION; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; ORGAN DONOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; DISEASE MODELS, ANIMAL; DNA; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; LIVER; LIVER TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 35448988443     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21251     Document Type: Article

References (40)

1. Varotti G, Grazi GL, Vetrone G, Ercolani G, Cescon M, Del Gaudio M, et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant 2005;19:492-500.
2. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993;55:807-813.
3. Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002;74:522-526.
4. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 1998;27:1172-1177.
5. Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998; 10:182-191.
6. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/ reperfusion injury - a fresh look. Exp Mol Pathol 2003;74:86-93.
7. Barton GM, Medzhitov R. Control of adaptive immune responses by toll-like receptors. Curr Opin Immunol 2002; 14:380-383.
8. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-387.
9. Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the toll-like family as surveillance receptors. Trends Immunol 2003;24:19-24.
10. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168:5233-5239.
11. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J Immunol 2001;167:2887-2894.
12. Zhai Y, Shen X, O'Connell R, Gao F, Lassman C, Busuttil R, et al. TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173:7115-7119.
13. Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, Cheng G, Kupiec-Weglinski JW. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/ reperfusion injury. Am J Transplant 2005;5:1793-1800.
14. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004;109:784-789.
15. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van't Veer C. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 2002;168:1286-1293.
16. Wu HS, Zhang JX, Wang L, Tian Y, Wang H, Rotstein O. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2004;3:250-253.
17. Shen XD, Gao F, Ke B, Zhai Y, Lassman CR, Tsuchihashi S, et al. Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation. Liver Transpl 2005;11: 1273-1281.
18. Tian Y, Rudiger HA, Jochum W, Clavien PA. Comparison of arterialized and nonarterialized orthotopic liver transplantation in mice: prowess or relevant model? Transplantation 2002;74:1242-1246.
19. Suzuki S, Toledo-Pereyra LH, Rodrigyez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993;55:1265-1272.
20. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14:157-167.
21. Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW. Interleukin 13 gene transfer in liver ischemia and reperfusion injury: role of Stat6 and TLR4 pathways in cytoprotection. Hum Gene Ther 2004;15:691-698.
22. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005;175:7661-7668.
23. Zhai Y, Qiao B, Gao F, Shen XD, Vardamian A, Busuttil RW, Kupiec-Weglinski JW. Type I, but not type II interferon is critical in liver ischemia/reperfusion. Hepatology (in press).
24. Tsung AR, Sahai H, Tanaka A, Nakao MP, Fink MT, Lotze H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005;201:1135-1143.
25. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004;76:514-519.
26. Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004;128:170-179.
27. Leemans JC Stockman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005;115:2894-2903.
28. Jiang D, Liang J, Li Y, Nobele PW. The role of Toll-like receptors in non-infectious lung injury. Cell Res 2006;16: 693-701.
29. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, et al. Upregulation of heme oxygenase-I protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999;104:1631-1639.
30. Sawitzki B, Amersi F, Ritter T, Fisser M, Shen XD, Ke B, et al. Upregulation of Bag-1 by ex-vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther 2002;13:1495-1504.
31. Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broc ME. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Trairsplant 2000;15:1562-74.
32. Rabb H, Daniels F, O'Donnell M, Haq M, Saba SR, Keane W, Tang WW. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000;279:F525-F531.
33. Rabb H. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 2002;61:1935-1946.
34. Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003;37:296-303.
35. Zhai Y, Shen HD, Hancock WW, Gao F, Qiao B, Lassman C, et al. CXCR3+ CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury. J Immunol 2006;176:6313-6322.
36. Fan C, Zwacka RM, Engelhardt JF. Therapeutic approach for ischemia/ reperfusion injury in the liver. J Mol Med 1999;77:577-592.
37. Bilbao G, Contreras JL, Eckhoff DE, Mikheeva G, Krasnykh V, Douglas JT, et al. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the anti-apoptotic Bel-2 gene. Ann Surg 1999;230:185-193.
38. Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavien PA, Gores GJ. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999;68:8996.
39. Antoku K, Maser RS, Scully WJ, Delach SM, Johnson DE. Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein. Biochem Biophys Res Commun 2001;286:1003-1010.
40. Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, et al. Ex-vivo exposure to carbon monoxide prevents hepatic ischemia/ reperfusion injury through p38 MAP kinase pathway. Hepatology 2002;35:815-823.